Endurant Capital Management as of Dec. 31, 2018
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 48 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 8.4 | $16M | 119k | 133.66 | |
| Cigna Corp (CI) | 7.1 | $14M | 71k | 189.92 | |
| Zimmer Holdings (ZBH) | 6.8 | $13M | 124k | 103.72 | |
| Celgene Corporation | 5.7 | $11M | 169k | 64.09 | |
| CVS Caremark Corporation (CVS) | 5.1 | $9.7M | 148k | 65.52 | |
| Medtronic (MDT) | 4.5 | $8.4M | 93k | 90.96 | |
| Shire | 4.2 | $8.0M | 46k | 174.03 | |
| Wright Medical Group Nv | 4.1 | $7.7M | 282k | 27.22 | |
| DaVita (DVA) | 3.8 | $7.2M | 141k | 51.46 | |
| R1 Rcm | 3.8 | $7.1M | 893k | 7.95 | |
| IntriCon Corporation | 3.5 | $6.5M | 248k | 26.38 | |
| Oxford Immunotec Global | 3.1 | $5.9M | 461k | 12.78 | |
| Allscripts Healthcare Solutions (MDRX) | 3.0 | $5.7M | 592k | 9.64 | |
| Hologic (HOLX) | 3.0 | $5.6M | 136k | 41.10 | |
| Icon (ICLR) | 2.8 | $5.3M | 41k | 129.22 | |
| Encompass Health Corp (EHC) | 2.8 | $5.3M | 85k | 61.70 | |
| Dentsply Sirona (XRAY) | 2.3 | $4.4M | 118k | 37.21 | |
| UnitedHealth (UNH) | 2.2 | $4.2M | 17k | 249.10 | |
| Sanofi-Aventis SA (SNY) | 1.9 | $3.5M | 81k | 43.41 | |
| Insulet Corporation (PODD) | 1.7 | $3.2M | 41k | 79.31 | |
| Bausch Health Companies (BHC) | 1.6 | $3.0M | 164k | 18.47 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $2.8M | 318k | 8.85 | |
| Bristol Myers Squibb (BMY) | 1.4 | $2.6M | 49k | 51.99 | |
| Fluidigm Corporation convertible cor | 1.3 | $2.5M | 2.8M | 0.92 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $2.4M | 22k | 109.14 | |
| Nevro (NVRO) | 1.1 | $2.1M | 55k | 38.89 | |
| Mylan Nv | 1.1 | $2.1M | 77k | 27.39 | |
| D Fluidigm Corp Del (LAB) | 1.1 | $2.0M | 237k | 8.62 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.9 | $1.8M | 232k | 7.75 | |
| PetMed Express (PETS) | 0.8 | $1.6M | 67k | 23.27 | |
| Accuray Incorporated (ARAY) | 0.8 | $1.6M | 455k | 3.41 | |
| Array BioPharma | 0.8 | $1.5M | 102k | 14.25 | |
| Irhythm Technologies (IRTC) | 0.7 | $1.3M | 18k | 69.49 | |
| Stryker Corporation (SYK) | 0.6 | $1.1M | 7.3k | 156.72 | |
| Teva Pharmaceutical Industries (TEVA) | 0.6 | $1.1M | 74k | 15.42 | |
| Boston Scientific Corporation (BSX) | 0.6 | $1.1M | 31k | 35.34 | |
| Ocular Therapeutix (OCUL) | 0.5 | $926k | 233k | 3.98 | |
| Johnson & Johnson (JNJ) | 0.5 | $850k | 6.6k | 129.02 | |
| Liquidia Technologies (LQDA) | 0.5 | $848k | 39k | 21.67 | |
| Axogen (AXGN) | 0.4 | $816k | 40k | 20.42 | |
| Anaptysbio Inc Common (ANAB) | 0.4 | $812k | 13k | 63.77 | |
| AmerisourceBergen (COR) | 0.3 | $620k | 8.3k | 74.34 | |
| Axsome Therapeutics (AXSM) | 0.3 | $590k | 209k | 2.82 | |
| McKesson Corporation (MCK) | 0.3 | $549k | 5.0k | 110.55 | |
| Amicus Therapeutics (FOLD) | 0.3 | $558k | 58k | 9.58 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $553k | 67k | 8.30 | |
| Viking Therapeutics (VKTX) | 0.2 | $409k | 54k | 7.65 | |
| Krystal Biotech (KRYS) | 0.1 | $260k | 13k | 20.80 |
